Inflammation and Diabetes: Evaluating Antioxidant Levels

Condition(s) studied

Investigational drug(s) / intervention(s)

No Interventions: No interventions

Study summary

The goal of this observational, cross-sectional study is to evaluate the relationships between dietary total antioxidant capacity, systemic inflammatory response markers, and nutritional parameters in adult patients with Type 2 Diabetes (T2DM). Participants will be classified into controlled (HbA1c \< %7) and uncontrolled (HbA1c ≥ %7) diabetes groups based on their glycemic control. The main questions it aims to answer are: Does dietary antioxidant capacity affect systemic inflammation levels and metabolic parameters? Is there a relationship between nutritional risk status and inflammatory response in T2DM patients?

Eligibility

Primary outcome measure(s)

• Composite Dietary Antioxidant Index (CDAI) — Baseline
  The Composite Dietary Antioxidant Index (CDAI) will be calculated to evaluate the total and synergistic effect of dietary antioxidants. It is based on the standardized daily intake of six main antioxidant components: Vitamin A, Vitamin C, Vitamin E, Magnesium, Selenium, and Zinc. Nutrient data will be obtained from food consumption records using the BeBiS 9 nutritional software. For each antioxidant nutrient, a unitless Z-score will be calculated by subtracting the population's mean intake from the individual's intake and dividing by the standard deviation.
• The Dietary Antioxidant Index — Baseline
  The Dietary Antioxidant Index (DAI) will be calculated based on the daily antioxidant intake obtained from the participants' food frequency questionnaire data. The main dietary antioxidant components (Vitamin C, Vitamin E, $\\beta$-carotene, flavonoids, and other polyphenols) will be quantitatively determined using the BeBiS 9 nutritional software. For each antioxidant component, the obtained values will be standardized into a Z-score by subtracting the mean intake of the study population from the individual's intake and dividing by the standard deviation. The individual's final DAI score will then be calculated by summing the Z-scores of all these components.
• Systemic Immune-Inflammation Index (SII) — Baseline
  Calculated from peripheral blood parameters using the formula: Platelet count × Neutrophil count / Lymphocyte count.
• Systemic Inflammation Response Index (SIRI) — Baseline
  Calculated using the formula: Neutrophil count × Monocyte count / Lymphocyte count.
• Triglyceride-Glucose (TyG) Index — Baseline
  Calculated using fasting plasma glucose and fasting triglyceride levels as an indirect marker of insulin resistance.
• Nutritional Assessment - Nutritional Risk Screening 2002 (NRS-2002) — Baseline
  The nutritional risk of the participants will be evaluated using the Nutritional Risk Screening 2002 (NRS-2002) tool. The NRS-2002 assesses impaired nutritional status and disease severity. The total score ranges from 0 to 7. A total score of 3 or higher indicates that the patient is at nutritional risk, while a score less than 3 indicates no immediate nutritional risk. The assessment will be administered by the researcher at the beginning of the study.
• Nutritional Assessment - Malnutrition Universal Screening Tool (MUST) — Baseline
  The nutritional risk of the participants will be evaluated using the Malnutrition Universal Screening Tool (MUST). MUST is a validated screening tool used to identify adults who are malnourished or at risk of malnutrition. The score is calculated based on three parameters: current body mass index (BMI), unintentional weight loss, and the effect of acute disease. The total score ranges from 0 to 6. A score of 0 indicates low risk, a score of 1 indicates medium risk, and a score of 2 or higher indicates a high risk of malnutrition. The assessment will be administered by the researcher at the beginning of the study.

Trial sites (1)

More Istanbul Bilgi University trials in Turkey

Other trials for the same condition